US Stock MarketDetailed Quotes

NMTRQ 9 METERS BIOPHARMA INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Oct 2 16:00 ET
14.46Market Cap0.00P/E (TTM)

9 METERS BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.01%-9.75M
-26.34%-37.24M
-22.18%-9.74M
-21.97%-9.97M
-9.53%-7.79M
-56.60%-9.75M
-51.87%-29.48M
-24.18%-7.97M
-96.42%-8.17M
-14.70%-7.11M
Net income from continuing operations
-22.17%-13.87M
-19.00%-43.77M
-24.86%-11.93M
30.91%-9.35M
-34.86%-11.13M
-109.01%-11.35M
40.19%-36.78M
-92.54%-9.55M
-62.48%-13.54M
81.49%-8.25M
Operating gains losses
--492.93K
-5,847.93%-416.36K
---339.36K
----
----
----
-100.18%-7K
--0
--0
--0
Depreciation and amortization
-18.32%1.33K
12.54%8.52K
-12.89%2.54K
18.33%1.57K
25.48%2.79K
46.58%1.63K
-59.04%7.57K
81.34%2.92K
-81.42%1.33K
-50.21%2.22K
Other non cash items
--578.9K
-12.17%2.33M
--1.33M
-80.83%500.35K
----
----
-91.90%2.65M
--0
18.79%2.61M
--0
Change In working capital
153.20%2.31M
-70.38%661.42K
-56.97%452.85K
-179.40%-1.77M
420.31%1.07M
172.71%911.78K
187.94%2.23M
155.69%1.05M
20.43%2.23M
138.09%205.07K
-Change in prepaid assets
55.57%1.78M
81.49%-368.67K
-529.89%-767.98K
40.94%-700.32K
88.68%-46.81K
524.70%1.15M
-346.96%-1.99M
-328.59%-121.92K
-16,237.70%-1.19M
27.81%-413.7K
-Change in payables and accrued expense
323.78%525.13K
-75.62%1.03M
3.96%1.22M
-131.33%-1.07M
80.00%1.11M
76.15%-234.67K
245.97%4.22M
160.44%1.17M
85.22%3.42M
1,681.34%618.77K
Cash from discontinued investing activities
Operating cash flow
-0.01%-9.75M
-26.34%-37.24M
-22.18%-9.74M
-21.97%-9.97M
-9.53%-7.79M
-56.60%-9.75M
-51.87%-29.48M
-24.18%-7.97M
-96.42%-8.17M
-14.70%-7.11M
Investing cash flow
Cash flow from continuing investing activities
0
99.88%-2.84K
0
0
0
43.30%-2.84K
23.73%-2.43M
-2.63K
-2.42M
99.94%-1.88K
Net PPE purchase and sale
--0
77.22%-2.84K
--0
--0
--0
43.30%-2.84K
-390.60%-12.48K
---2.63K
---2.96K
26.07%-1.88K
Net intangibles purchase and sale
----
--0
--0
----
----
----
21.71%-2.49M
--0
----
----
Net other investing changes
----
----
----
----
----
----
--75K
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
99.88%-2.84K
--0
--0
--0
43.30%-2.84K
23.73%-2.43M
---2.63K
---2.42M
99.94%-1.88K
Financing cash flow
Cash flow from continuing financing activities
-12.29M
-51.49%19.91M
0
10,960.15%19.91M
0
0
-26.50%41.05M
-95.73%1.36M
-94.24%180.03K
61.65%32.64M
Net issuance payments of debt
---16.75M
36,183.09%21M
--0
--21M
--0
--0
-251.06%-58.2K
--0
--0
--0
Net common stock issuance
--5M
--0
--0
--0
--0
--0
-7.13%34.5M
--0
--0
----
Proceeds from stock option exercised by employees
----
--0
--0
--0
----
----
276.10%9.51M
181.36%1.36M
-48.00%430.03K
-35.26%789.18K
Net other financing activities
---537.68K
62.49%-1.09M
--0
----
----
----
54.82%-2.9M
--0
-241.77%-250K
----
Cash from discontinued financing activities
Financing cash flow
---12.29M
-51.49%19.91M
--0
10,960.15%19.91M
--0
--0
-26.50%41.05M
-95.73%1.36M
-94.24%180.03K
61.65%32.64M
Net cash flow
Beginning cash position
-36.89%29.66M
24.15%46.99M
-26.51%39.4M
-53.99%29.46M
-3.26%37.24M
24.15%46.99M
724.12%37.85M
331.08%53.61M
375.18%64.02M
1,343.02%38.5M
Current changes in cash
-125.98%-22.04M
-289.61%-17.33M
-47.21%-9.74M
195.46%9.94M
-130.50%-7.79M
-1,612.47%-9.75M
-72.51%9.14M
-126.03%-6.62M
-903.86%-10.41M
136.24%25.53M
End cash Position
-79.53%7.62M
-36.89%29.66M
-36.89%29.66M
-26.51%39.4M
-53.99%29.46M
-3.26%37.24M
24.15%46.99M
24.15%46.99M
331.08%53.61M
375.18%64.02M
Free cash flow
0.02%-9.75M
-16.45%-37.25M
-22.14%-9.74M
6.56%-9.97M
-9.50%-7.79M
-56.52%-9.75M
-41.54%-31.98M
-24.22%-7.97M
-156.41%-10.67M
24.23%-7.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.01%-9.75M-26.34%-37.24M-22.18%-9.74M-21.97%-9.97M-9.53%-7.79M-56.60%-9.75M-51.87%-29.48M-24.18%-7.97M-96.42%-8.17M-14.70%-7.11M
Net income from continuing operations -22.17%-13.87M-19.00%-43.77M-24.86%-11.93M30.91%-9.35M-34.86%-11.13M-109.01%-11.35M40.19%-36.78M-92.54%-9.55M-62.48%-13.54M81.49%-8.25M
Operating gains losses --492.93K-5,847.93%-416.36K---339.36K-------------100.18%-7K--0--0--0
Depreciation and amortization -18.32%1.33K12.54%8.52K-12.89%2.54K18.33%1.57K25.48%2.79K46.58%1.63K-59.04%7.57K81.34%2.92K-81.42%1.33K-50.21%2.22K
Other non cash items --578.9K-12.17%2.33M--1.33M-80.83%500.35K---------91.90%2.65M--018.79%2.61M--0
Change In working capital 153.20%2.31M-70.38%661.42K-56.97%452.85K-179.40%-1.77M420.31%1.07M172.71%911.78K187.94%2.23M155.69%1.05M20.43%2.23M138.09%205.07K
-Change in prepaid assets 55.57%1.78M81.49%-368.67K-529.89%-767.98K40.94%-700.32K88.68%-46.81K524.70%1.15M-346.96%-1.99M-328.59%-121.92K-16,237.70%-1.19M27.81%-413.7K
-Change in payables and accrued expense 323.78%525.13K-75.62%1.03M3.96%1.22M-131.33%-1.07M80.00%1.11M76.15%-234.67K245.97%4.22M160.44%1.17M85.22%3.42M1,681.34%618.77K
Cash from discontinued investing activities
Operating cash flow -0.01%-9.75M-26.34%-37.24M-22.18%-9.74M-21.97%-9.97M-9.53%-7.79M-56.60%-9.75M-51.87%-29.48M-24.18%-7.97M-96.42%-8.17M-14.70%-7.11M
Investing cash flow
Cash flow from continuing investing activities 099.88%-2.84K00043.30%-2.84K23.73%-2.43M-2.63K-2.42M99.94%-1.88K
Net PPE purchase and sale --077.22%-2.84K--0--0--043.30%-2.84K-390.60%-12.48K---2.63K---2.96K26.07%-1.88K
Net intangibles purchase and sale ------0--0------------21.71%-2.49M--0--------
Net other investing changes --------------------------75K--0--------
Cash from discontinued investing activities
Investing cash flow --099.88%-2.84K--0--0--043.30%-2.84K23.73%-2.43M---2.63K---2.42M99.94%-1.88K
Financing cash flow
Cash flow from continuing financing activities -12.29M-51.49%19.91M010,960.15%19.91M00-26.50%41.05M-95.73%1.36M-94.24%180.03K61.65%32.64M
Net issuance payments of debt ---16.75M36,183.09%21M--0--21M--0--0-251.06%-58.2K--0--0--0
Net common stock issuance --5M--0--0--0--0--0-7.13%34.5M--0--0----
Proceeds from stock option exercised by employees ------0--0--0--------276.10%9.51M181.36%1.36M-48.00%430.03K-35.26%789.18K
Net other financing activities ---537.68K62.49%-1.09M--0------------54.82%-2.9M--0-241.77%-250K----
Cash from discontinued financing activities
Financing cash flow ---12.29M-51.49%19.91M--010,960.15%19.91M--0--0-26.50%41.05M-95.73%1.36M-94.24%180.03K61.65%32.64M
Net cash flow
Beginning cash position -36.89%29.66M24.15%46.99M-26.51%39.4M-53.99%29.46M-3.26%37.24M24.15%46.99M724.12%37.85M331.08%53.61M375.18%64.02M1,343.02%38.5M
Current changes in cash -125.98%-22.04M-289.61%-17.33M-47.21%-9.74M195.46%9.94M-130.50%-7.79M-1,612.47%-9.75M-72.51%9.14M-126.03%-6.62M-903.86%-10.41M136.24%25.53M
End cash Position -79.53%7.62M-36.89%29.66M-36.89%29.66M-26.51%39.4M-53.99%29.46M-3.26%37.24M24.15%46.99M24.15%46.99M331.08%53.61M375.18%64.02M
Free cash flow 0.02%-9.75M-16.45%-37.25M-22.14%-9.74M6.56%-9.97M-9.50%-7.79M-56.52%-9.75M-41.54%-31.98M-24.22%-7.97M-156.41%-10.67M24.23%-7.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data